I used to be a type II diabetic. My HbA1C hovered around 8%, even while taking metformin and Jardiance. Every doctor told me the same thing: type II diabetes is progressive, lifelong, and inevitably leads to complications. I accepted it — I exercised, took my medications, and tried to make peace with that prognosis.
Then came COVID, and it completely changed how I saw my health. I began questioning what I had been told and discovered that much of it simply wasn’t true. With surprisingly simple lifestyle changes — eating real, unprocessed food, incorporating intermittent fasting, and losing weight — I reversed my diabetes. Today, my HbA1C is 4.9%.
My name is Paul, and this is my story. It could just as easily be yours.
Over the past half century, a profound shift has occurred in the global burden of disease. Conditions once considered distinct—type 2 diabetes, cardiovascular disease, obesity, and even aspects of cancer and neurodegeneration—are increasingly recognized as interconnected manifestations of a single underlying disorder: insulin resistance.
Insulin resistance is not merely a biochemical abnormality. It is a systemic failure of metabolic regulation—an adaptive response to chronic nutritional excess and environmental mismatch. At its clinical extreme, this process is expressed as metabolic syndrome, a constellation of abnormalities that now affects more than one-third of adults in the United States and approximately one-quarter of the global population.
Importantly, insulin resistance precedes overt disease by years, often decades. It is therefore both a predictor and a driver of chronic illness. Understanding its biology provides not only insight into disease pathogenesis, but also a powerful framework for prevention and reversal.
